Antimicrobial Agents Practice Questions

Q: Which of the following protein synthesis inhibitors is a non-plant toxin?

Streptomycin. This question tests the ability to differentiate between therapeutic antimicrobial agents and naturally occurring biological toxins that share a common mechanism: the inhibition of protein synthesis. ### **Explanation of the Correct Answer** **Streptomycin (Option A)** is an **aminoglycoside antibiotic** derived from the soil bacterium *Streptomyces griseus*. It inhibits protein synthesis by binding to the **30S ribosomal subunit** of bacteria, causing misreading of mRNA and inhibition of the initiation complex. Unlike the other options, it is a clinically used pharmaceutical agent and is **not a plant toxin**. ### **Analysis of Incorrect Options** * **Abrin (Option B):** A highly potent toxalbumin found in the seeds of the **Rosary Pea (*Abrus precatorius*)**. It is a Type II Ribosome-Inactivating Protein (RIP) that inhibits the 60S ribosomal subunit by removing adenine from rRNA. * **Ricin (Option C):** A lethal toxin derived from the **Castor bean (*Ricinus communis*)**. Similar to abrin, it is a plant-derived RIP that halts protein synthesis at the 60S subunit, leading to cell death. * **Emetine (Option D):** An alkaloid derived from the **Ipecacuanha plant**. While historically used as an anti-amoebic, it acts by inhibiting protein synthesis in eukaryotic cells (40S subunit). It is considered a plant-derived alkaloid/toxin rather than a standard antibiotic. ### **High-Yield Clinical Pearls for NEET-PG** * **Mechanism of Streptomycin:** It is bactericidal (unlike most protein synthesis inhibitors which are bacteriostatic) and is a first-line drug for **Tuberculosis**. * **Adverse Effects:** Ototoxicity (vestibular > auditory) and Nephrotoxicity. * **Ribosomal Targets:** * **30S Inhibitors:** Aminoglycosides, Tetracyclines. * **50S Inhibitors:** Chloramphenicol, Macrolides, Clindamycin, Linezolid. * **60S (Eukaryotic) Inhibitors:** Ricin, Abrin, Shiga toxin.

Q: All of the following are beta-lactamase inhibitors except?

Aztreonam. ### Explanation The correct answer is **D. Aztreonam**. **1. Why Aztreonam is the correct answer:** Aztreonam is a **Monobactam**, which is a class of beta-lactam antibiotics. Unlike beta-lactamase inhibitors, which have little to no intrinsic antibacterial activity and are used to protect other antibiotics, Aztreonam is a potent bactericidal agent. It specifically targets **Gram-negative aerobic bacteria** (including *Pseudomonas*) by binding to penicillin-binding protein 3 (PBP-3). It is unique because it is resistant to many beta-lactamases but is **not** an inhibitor itself. **2. Why the other options are incorrect:** * **Clavulanic acid, Sulbactam, and Tazobactam** are classic **"Suicide Inhibitors."** They contain a beta-lactam ring but possess negligible antimicrobial activity. Instead, they bind irreversibly to the beta-lactamase enzymes produced by bacteria, preventing the enzymes from destroying co-administered antibiotics like Amoxicillin, Ampicillin, or Piperacillin. **3. High-Yield Clinical Pearls for NEET-PG:** * **Aztreonam's "Safety Profile":** It is the only beta-lactam that shows **no cross-reactivity** with penicillins (except for Ceftazidime due to a similar side chain). It is the drug of choice for Gram-negative infections in patients with a severe penicillin allergy. * **Newer Beta-lactamase Inhibitors:** Beyond the options listed, remember **Avibactam, Relebactam, and Vaborbactam**. Unlike the older "suicide inhibitors," Avibactam does not have a beta-lactam ring (it is a diazabicyclooctane). * **Spectrum:** Beta-lactamase inhibitors are typically effective against Class A beta-lactamases (like those from *S. aureus*, *H. influenzae*) but are often ineffective against AmpC or Carbapenemases (except for the newer agents like Avibactam).

Q: Which of the following is not nephrotoxic?

Ampicillin. ### Explanation The correct answer is **Ampicillin**. **1. Why Ampicillin is the correct choice:** Ampicillin is a penicillin-class antibiotic. Penicillins are generally considered safe for the kidneys because they are primarily excreted via active tubular secretion without causing direct damage to the renal parenchyma. While they can rarely cause **Acute Interstitial Nephritis (AIN)**—an immune-mediated hypersensitivity reaction—they are not inherently **nephrotoxic** (toxic to renal cells). **2. Why the other options are incorrect:** * **Tobramycin & Kanamycin (Aminoglycosides):** These are notorious for causing **Acute Tubular Necrosis (ATN)**. They accumulate in the proximal convoluted tubule (PCT) cells, leading to dose-dependent, reversible renal failure. Neomycin is the most nephrotoxic, while Streptomycin is the least. * **Amphotericin B:** This antifungal is highly nephrotoxic. It causes renal vasoconstriction and direct damage to the distal tubular membranes, often leading to "Type 1 Renal Tubular Acidosis" and significant electrolyte wasting (hypokalemia and hypomagnesemia). **3. NEET-PG High-Yield Clinical Pearls:** * **Aminoglycoside Nephrotoxicity:** It is usually non-oliguric. Monitoring serum creatinine is essential. * **Amphotericin B:** To reduce its nephrotoxicity, clinicians use **Liposomal formulations** or "salt loading" (pre-infusion with normal saline). * **Drug of Choice for AIN:** If a patient develops hematuria and eosinophiluria after taking Ampicillin or Methicillin, the diagnosis is AIN; the immediate step is to stop the drug. * **Other common nephrotoxic drugs:** Cisplatin, Cyclosporine, NSAIDs, and Radiocontrast dyes.

Q: Testing of HLA-B57:07 is recommended prior to the initiation of which of the following anti-retroviral agents?

Abacavir. **Explanation:** The correct answer is **Abacavir (Option D)**. **1. Why Abacavir is correct:** Abacavir is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment. Its use is strongly associated with a potentially life-threatening **Abacavir Hypersensitivity Reaction (HSR)**. This reaction is a Type IV (delayed) hypersensitivity mediated by T-cells. There is a definitive genetic predisposition: patients carrying the **HLA-B*57:01** allele are at a significantly higher risk (approx. 50%) of developing HSR. Therefore, international guidelines (and NEET-PG high-yield facts) mandate screening for this allele before starting Abacavir. If positive, the drug is contraindicated. **2. Why other options are incorrect:** * **Atazanavir (A):** A Protease Inhibitor (PI) known for causing unconjugated hyperbilirubinemia (jaundice) due to UGT1A1 inhibition, but it does not require HLA testing. * **Nelfinavir (B):** An older PI primarily associated with gastrointestinal side effects (diarrhea). No HLA association exists. * **Raltegravir (C):** An Integrase Strand Transfer Inhibitor (INSTI). While it can cause rare skin rashes or SJS, there is no routine genetic screening required for its initiation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation of HSR:** Fever, rash, GI symptoms (nausea/vomiting), and respiratory symptoms (cough/dyspnea) occurring within the first 6 weeks. * **The "Gold Standard" Rule:** Never "re-challenge" a patient with Abacavir if HSR is suspected; it can lead to fatal anaphylaxis. * **Other HLA-Drug Associations:** * **HLA-B*15:02:** Carbamazepine (SJS/TEN risk in Asians). * **HLA-B*58:01:** Allopurinol (Severe cutaneous adverse reactions). * **HLA-DQB1*06:02:** Clozapine (Agranulocytosis).

Q: Which of the following anti-tubercular drugs should be avoided in pregnancy?

Pyrazinamide. ### Explanation In the management of Tuberculosis during pregnancy, the primary goal is to balance maternal health with fetal safety. According to the **WHO** and **RNTCP (India)** guidelines, most first-line anti-tubercular drugs are considered safe, but certain precautions are taken regarding Pyrazinamide. **Why Pyrazinamide is the correct answer:** While there is no definitive evidence of teratogenicity, **Pyrazinamide (Z)** is traditionally avoided in pregnancy because there is **insufficient data** regarding its safety on the developing fetus. In many international guidelines (including older US-CDC protocols), the preferred regimen for pregnant women is a 9-month course of Isoniazid, Rifampicin, and Ethambutol, omitting Pyrazinamide unless multidrug resistance is suspected. **Analysis of Incorrect Options:** * **Rifampicin (A):** Considered safe in pregnancy. However, it can induce hepatic enzymes and may lead to Vitamin K deficiency in the neonate; thus, prophylactic Vitamin K is recommended for the newborn. * **Isoniazid (B):** Considered safe. To prevent peripheral neuropathy in the mother (due to increased demand), **Pyridoxine (Vitamin B6)** supplementation is mandatory. * **Ethambutol (D):** Considered the safest first-line drug in pregnancy with no known teratogenic effects. **NEET-PG High-Yield Pearls:** 1. **Streptomycin** is strictly **contraindicated** in pregnancy as it is ototoxic and can cause permanent 8th cranial nerve damage (deafness) in the fetus. 2. **Standard Protocol:** The current WHO/RNTCP recommendation for pregnant women with TB is the standard **6-month 2HREZ/4HR** regimen, as the benefits of treating the mother outweigh the theoretical risks of Pyrazinamide. However, for exam purposes, if asked which drug is "avoided" or has "least safety data," Pyrazinamide remains the choice. 3. **Breastfeeding:** All first-line drugs are compatible with breastfeeding.

Q: Isoniazid-induced peripheral neuropathy results from a deficiency of which vitamin?

Vitamin B6. ### Explanation **Correct Option: D (Vitamin B6 / Pyridoxine)** **Mechanism:** Isoniazid (INH) is a structural analog of pyridoxine. It induces peripheral neuropathy through two primary mechanisms: 1. **Competitive Inhibition:** INH inhibits the enzyme **pyridoxine phosphokinase**, which is essential for converting pyridoxine into its active form, **pyridoxal phosphate (PLP)**. 2. **Increased Excretion:** INH reacts with pyridoxine to form **isoniazid-pyridoxal hydrazones**, which are rapidly excreted in the urine. PLP is a vital co-factor for the synthesis of neurotransmitters (like GABA). Its deficiency leads to axonal degeneration, manifesting clinically as "glove and stocking" paresthesia. **Why Incorrect Options are Wrong:** * **Vitamin B1 (Thiamine):** Deficiency causes Beriberi (Dry/Wet) and Wernicke-Korsakoff syndrome, typically seen in chronic alcoholism, not INH therapy. * **Vitamin B2 (Riboflavin):** Deficiency leads to cheilosis, glossitis, and corneal vascularization. * **Vitamin B12 (Cobalamin):** Deficiency causes Subacute Combined Degeneration (SCD) of the spinal cord and megaloblastic anemia. **NEET-PG Clinical Pearls:** * **Prophylaxis:** To prevent neuropathy, **10–50 mg/day** of Pyridoxine is co-administered with INH. * **Risk Groups:** Neuropathy is more common in **slow acetylators** (due to higher drug levels), malnourished individuals, diabetics, and chronic alcoholics. * **Other Side Effects:** INH is also associated with **Hepatotoxicity** (most common side effect) and **Drug-induced Lupus** (anti-histone antibodies positive). * **Sideroblastic Anemia:** INH can also cause this because PLP is a cofactor for **ALA synthase**, the rate-limiting enzyme in heme synthesis.

Q: On which of the following does pyrazinamide act?

Tuberculous bacilli in macrophages. **Explanation:** Pyrazinamide (PZA) is a critical first-line anti-tubercular drug known for its unique ability to target **intracellular mycobacteria** residing within macrophages. **1. Why Option C is Correct:** Pyrazinamide is a prodrug converted into its active form, **pyrazinoic acid**, by the enzyme *nicotinamidase (pyrazinamidase)*. This conversion occurs most efficiently in **acidic environments** (pH 5.0–5.5). In the body, such acidic conditions are found specifically within the **phagolysosomes of macrophages**. Therefore, PZA is highly effective against "slowly multiplying" intracellular bacilli that other drugs (like Streptomycin) cannot reach. This makes it a potent **sterilizing agent**, crucial for shortening the duration of TB treatment from 9 months to 6 months. **2. Why Other Options are Incorrect:** * **Option A:** This describes the mechanism of **Sulfonamides** or **Para-aminosalicylic acid (PAS)**, which inhibit dihydropteroate synthase. * **Option B:** Pyrazinamide is primarily **bactericidal**, not bacteriostatic, particularly in acidic environments. It targets dormant/persistent organisms rather than rapidly growing ones. * **Option D:** Bacilli in the bloodstream or in well-oxygenated extracellular cavities are usually in a neutral or alkaline environment. PZA has negligible activity at physiological pH (7.4); drugs like **Isoniazid** and **Rifampin** are more effective here. **High-Yield Clinical Pearls for NEET-PG:** * **Most common side effect:** Hyperuricemia (due to inhibition of uric acid excretion), which may precipitate **acute gouty arthritis**. * **Most serious side effect:** Hepatotoxicity (dose-dependent). * **Resistance:** Occurs due to mutations in the **pncA gene**, which encodes the pyrazinamidase enzyme. * **Role in RNTCP:** It is used only in the **Intensive Phase** (first 2 months) of Short-Course Chemotherapy.

Q: What is the recommended prophylaxis for H1N1 influenza?

Oseltamivir. **Explanation:** **Oseltamivir (Option A)** is the drug of choice for both the treatment and prophylaxis of H1N1 influenza. It belongs to the **Neuraminidase Inhibitors** class. Neuraminidase is an enzyme essential for the release of newly formed viral particles from infected host cells; by inhibiting this enzyme, Oseltamivir prevents the spread of the virus within the respiratory tract. It is preferred for prophylaxis because it is administered **orally**, making it convenient for outpatient use and mass distribution during outbreaks. **Why other options are incorrect:** * **Zanamivir (Option B):** While also a neuraminidase inhibitor effective against H1N1, it is administered via **inhalation**. This makes it unsuitable for patients with underlying airway diseases (like asthma or COPD) due to the risk of bronchospasm, and less practical for general prophylaxis compared to oral Oseltamivir. * **Amantadine and Rimantadine (Options C & D):** These are **M2 ion channel blockers**. They are only effective against Influenza A and have no activity against Influenza B. More importantly, most current strains of H1N1 have developed widespread high-level resistance to these drugs, rendering them obsolete for H1N1 prophylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** For effective prophylaxis, Oseltamivir should ideally be started within **48 hours** of exposure. * **Pregnancy:** Oseltamivir is considered the safest antiviral for pregnant women with H1N1. * **Side Effects:** The most common side effects of Oseltamivir are nausea and vomiting (taking it with food helps). * **Baloxavir Marboxil:** A newer drug (Cap-dependent endonuclease inhibitor) is now used for treatment but Oseltamivir remains the standard for prophylaxis in most guidelines.

Q: The antiviral drug recommended for treatment of Herpes Zoster infection of Trigeminal nerve distribution in an immunocompromised host is?

Famciclovir. **Explanation:** The clinical scenario describes **Herpes Zoster (Shingles)** involving the trigeminal nerve (Ophthalmic division involvement can lead to Herpes Zoster Ophthalmicus) in an **immunocompromised host**. In such cases, prompt and potent antiviral therapy is mandatory to prevent complications like post-herpetic neuralgia or ocular damage. **Why Famciclovir is correct:** Famciclovir is a prodrug of penciclovir. It is highly effective against Varicella-Zoster Virus (VZV). In immunocompromised patients, oral **Famciclovir** or **Valacyclovir** are preferred over Acyclovir due to their superior bioavailability and less frequent dosing schedules. They achieve higher intracellular concentrations, which is crucial for treating aggressive VZV infections in high-risk patients. **Analysis of Incorrect Options:** * **A. Fomivirsen:** This is an antisense oligonucleotide used specifically for the local (intravitreal) treatment of **CMV retinitis** in HIV patients. It is not used for VZV. * **B. Vidarabine:** An older antiviral (Adenine Arabinoside) that was used for Herpes Simplex Encephalitis. It is rarely used today due to high systemic toxicity compared to modern alternatives like Acyclovir. * **D. Entecavir:** This is a potent nucleoside analog used specifically for the treatment of **Chronic Hepatitis B** infection. It has no clinical utility against the Herpes virus family. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** For Herpes Zoster in immunocompromised patients, the DOC is **Intravenous Acyclovir** if the infection is severe/disseminated; however, for stable patients, **Famciclovir** or **Valacyclovir** are the preferred oral agents. * **Mechanism:** Famciclovir requires viral **Thymidine Kinase** for initial phosphorylation (activation). * **Post-Herpetic Neuralgia (PHN):** Early administration of Famciclovir (within 72 hours) significantly reduces the duration and severity of PHN.

Question 1

Which of the following protein synthesis inhibitors is a non-plant toxin?

Accepted Answer

Streptomycin

Answer

Abrin

Answer

Ricin

Answer

Emetine

Question 2

All of the following are beta-lactamase inhibitors except?

Accepted Answer

Aztreonam

Answer

Clavulanic acid

Answer

Sulbactam

Answer

Tazobactam

Question 3

Which of the following is not nephrotoxic?

Accepted Answer

Ampicillin

Answer

Tobramycin

Answer

Kanamycin

Answer

Amphotericin B

Question 4

Testing of HLA-B57:07 is recommended prior to the initiation of which of the following anti-retroviral agents?

Accepted Answer

Abacavir

Answer

Atazanavir

Answer

Nelfinavir

Answer

Raltegravir

Question 5

Which of the following anti-tubercular drugs should be avoided in pregnancy?

Accepted Answer

Pyrazinamide

Answer

Rifampicin

Answer

Isoniazid

Answer

Ethambutol

Question 6

Isoniazid-induced peripheral neuropathy results from a deficiency of which vitamin?

Accepted Answer

Vitamin B6

Answer

Vitamin B1

Answer

Vitamin B2

Answer

Vitamin B12

Question 7

What is the mechanism of action by which pyrantel pamoate is effective for the treatment of Necator americanus (hookworm) disease?

Accepted Answer

Inhibition of neuromuscular transmission

Answer

Interference with cell-wall synthesis

Answer

Interference with cell division

Answer

Depletion of membrane lipoproteins

Question 8

On which of the following does pyrazinamide act?

Accepted Answer

Tuberculous bacilli in macrophages

Answer

Interfering with folic acid biosynthesis of mycobacteria

Answer

Bacteriostatic activity on growing organisms

Answer

Tuberculous bacilli in the bloodstream

Question 9

What is the recommended prophylaxis for H1N1 influenza?

Accepted Answer

Oseltamivir

Answer

Zanamivir

Answer

Amantadine

Answer

Rimantadine

Question 10

The antiviral drug recommended for treatment of Herpes Zoster infection of Trigeminal nerve distribution in an immunocompromised host is?

Accepted Answer

Famciclovir

Answer

Fomivirsen

Answer

Vidarabin

Answer

Entecavir

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?